Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2.
暂无分享,去创建一个
Mustafa Usta | Ans Punt | Ivonne M C M Rietjens | Sabina Bijlsma | Nicole H P Cnubben | S. Bijlsma | H. Wortelboer | J. V. van Zanden | N. Cnubben | I. Rietjens | M. Usta | A. Punt | Jelmer J van Zanden | Heleen M Wortelboer | Peter J van Bladeren | P. J. Bladeren
[1] A. di Pietro,et al. Recent advances in the discovery of flavonoids and analogs with high‐affinity binding to P‐glycoprotein responsible for cancer cell multidrug resistance , 2002, Medicinal research reviews.
[2] H. Daniel,et al. Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines , 1999, European journal of nutrition.
[3] M. Kool,et al. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. , 1998, The Journal of clinical investigation.
[4] S. Cole,et al. Glutathione Stimulates Sulfated Estrogen Transport by Multidrug Resistance Protein 1* , 2001, The Journal of Biological Chemistry.
[5] P. van Bladeren,et al. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin. , 2003, Chemical research in toxicology.
[6] A. Sparreboom,et al. Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[7] B. Norman. Inhibitors of MRP1-mediated multidrug resistance , 1998 .
[8] Liesbeth Geraets,et al. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. , 2004, Biochemical pharmacology.
[9] S. Hladky,et al. Influences of glutathione on anionic substrate efflux in tumour cells expressing the multidrug resistance-associated protein, MRP1. , 2001, Biochemical pharmacology.
[10] P. Hollman,et al. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. , 1996, Free radical biology & medicine.
[11] A. di Pietro,et al. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Molnár,et al. Flavonoids as inhibitors of MRP1-like efflux activity in human erythrocytes. A structure-activity relationship study. , 2003, Oncology research.
[13] M. Kool,et al. A family of drug transporters: the multidrug resistance-associated proteins. , 2000, Journal of the National Cancer Institute.
[14] Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1). , 2002, Bioorganic & medicinal chemistry letters.
[15] T. Uchiumi,et al. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter. , 1999, Molecular pharmacology.
[16] S. Cole,et al. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. , 2001, Molecular pharmacology.
[17] D. Keppler,et al. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2. , 1998, Chemico-biological interactions.
[18] A. Goffeau,et al. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters , 2002, Cellular and Molecular Life Sciences CMLS.
[19] D. Keppler,et al. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. , 1999, Biochimica et biophysica acta.
[20] G. Szakács,et al. Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1. , 1998, Anticancer research.
[21] T. Walle,et al. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. , 1999, Biochemical pharmacology.
[22] M. Essodaigui,et al. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. , 1998, Biochemistry.
[23] D. Keppler,et al. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. , 1999, Molecular pharmacology.
[24] C. Higgins,et al. ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.
[25] P. Borst,et al. ABC transporters in lipid transport. , 2000, Biochimica et biophysica acta.
[26] P. Borst,et al. Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.
[27] M. Veit,et al. Pharmacokinetics and bioavailability of the flavonol quercetin in humans. , 1999, International journal of clinical pharmacology and therapeutics.
[28] Henryk Szymusiak,et al. Prooxidant toxicity of polyphenolic antioxidants to HL‐60 cells: description of quantitative structure‐activity relationships , 1999, FEBS letters.
[29] J. Lankelma,et al. Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein , 1997, FEBS letters.
[30] R. Evers,et al. Transport of glutathione prostaglandin A conjugates by the multidrug resistance protein 1 , 1997, FEBS letters.
[31] D. Keppler,et al. Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAJ) gene in liver , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[32] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[33] R. Walgren,et al. Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. , 2000, The Journal of pharmacology and experimental therapeutics.
[34] K. Tomisawa,et al. Inhibition of gastric H+, K(+)-ATPase by flavonoids: a structure-activity study. , 1999, Journal of enzyme inhibition.
[35] M. Morris,et al. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. , 2003, Journal of Pharmacy and Science.
[36] S. Cole,et al. Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. , 1998, Cancer research.
[37] P. Jansen,et al. The (patho)physiological functions of the MRP family. , 2000, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[38] P. Jansen,et al. ATP‐ and glutathione‐dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1 , 1999, British journal of pharmacology.
[39] J. Tolan,et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.